The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cance...

Por Meyerhardt, Jeffrey A., Sargent, Daniel, Paul, James, Sobrero, Alberto, André, Thierry, Shields, Anthony F., Yoshino, Takayuki, Souglakos, Ioannis, Iveson, Timothy, Labianca, Roberto, Taieb, Julien, Ohtsu, Atsushi, Grothey, Axel
Publicado no Gastrointest Cancer Res (2014)

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy wi...

Por André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.
Publicado em 2013

Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus

Por Noble, Fergus, Nolan, Luke, Bateman, Adrian C, Byrne, James P, Kelly, Jamie J, Bailey, Ian S, Sharland, Donna M, Rees, Charlotte N, Iveson, Timothy J, Underwood, Tim J, Bateman, Andrew R
Publicado em 2013

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phas...

Por Waddell, Tom, Chau, Ian, Cunningham, David, Gonzalez, David, Okines, Alicia Frances Clare, Wotherspoon, Andrew, Saffery, Claire, Middleton, Gary, Wadsley, Jonathan, Ferry, David, Mansoor, Wasat, Crosby, Tom, Coxon, Fareeda, Smith, David, Waters, Justin, Iveson, Timothy, Falk, Stephen, Slater, Sarah, Peckitt, Clare, Barbachano, Yolanda
Publicado em 2013